Cracks beneath the smile: Dentists flag rising “Ozempic Teeth” cases linked to popular weight-loss drugs
As demand for GLP-1 weight-loss drugs like Ozempic surges, dental professionals are noticing an unsettling trend—an increase in reports of dry mouth, enamel erosion and unexpected dental damage among users.
Weight-loss injections such as Ozempic, Wegovy, and Mounjaro have soared in popularity over the past year. Marketed for diabetes and weight management, these medications—part of the GLP-1 receptor agonist drug class—are now widely prescribed across both medical and lifestyle settings. But as their use becomes more mainstream, a lesser-known complication has emerged, raising new questions about patient care.
Dentists in the UK, US, and beyond are now reporting what some are informally referring to as “Ozempic teeth”—a pattern of unexpected dental deterioration observed among individuals taking these medications. While formal studies remain ongoing, anecdotal evidence suggests a possible connection between the drug class and a variety of oral health issues.
From Slimming to Sensitive: What Patients Are Reporting

Several patients have described cracked teeth, sudden tooth loss, increased oral sensitivity, and persistent dry mouth after beginning GLP-1 therapies. Some dental clinics have also noted a rise in emergency appointments from individuals with no prior history of major dental issues.
Common complaints include:
- A chalky or brittle feel to teeth
- Heightened gum irritation or bleeding
- Difficulty chewing or brushing comfortably
- Unexpected tooth fractures despite regular hygiene
One possible explanation, experts suggest, is the reduction in saliva production—a known side effect of many medications, including GLP-1 agonists. Saliva helps to maintain the pH of the mouth, wash away food particles, and protect enamel from bacterial acid. Without adequate saliva, patients may become more vulnerable to cavities and decay.
Appetite, Nutrition, and Dental Wellbeing
Another contributing factor could be changes in diet and nutrient intake. Because these drugs significantly reduce appetite, some users consume far fewer calories than usual. This may inadvertently reduce their intake of key nutrients, including calcium, magnesium, and vitamin D—all essential for oral health.
Additionally, gastrointestinal side effects such as reflux or vomiting, sometimes reported during the adjustment period of the medication, may expose teeth to higher levels of stomach acid, increasing enamel erosion over time.
However, it’s important to note that not all individuals using Ozempic or similar medications experience oral health complications, and existing dental conditions, dietary habits, and hygiene routines are also likely to influence outcomes.
Caution Without Panic
While the term “Ozempic teeth” has gained traction online, dental associations have urged caution in drawing direct causal links. At present, no definitive clinical guidance has been issued connecting GLP-1 medications with accelerated dental decay. Nevertheless, clinicians are encouraging open communication between patients, GPs, and dental providers to monitor changes and act proactively.
Some practices have begun asking patients if they are taking GLP-1 medications during routine check-ups, enabling them to offer personalised oral care plans or flag early warning signs of deterioration.
Preventative Tips for Patients
Individuals prescribed Ozempic or related medications may benefit from a few simple steps to help support their oral health:
- Stay well hydrated to offset dry mouth symptoms
- Use fluoride toothpaste or rinses for added enamel protection
- Avoid excessive acidic foods that can compound enamel wear
- Schedule regular dental reviews, particularly in the first six months of treatment
- Report any sudden oral discomfort or changes in chewing, speaking or hygiene tolerance
As with any medical intervention, the best outcomes are often achieved through collaboration between healthcare providers and ongoing self-monitoring.
A Wider Look at Medication Impacts
The emergence of oral health concerns in connection with popular weight-loss drugs is part of a broader conversation about the long-term effects of new pharmaceuticals being used for lifestyle shifts. While GLP-1 drugs continue to offer significant benefits for weight management and blood sugar control, secondary effects—whether gastrointestinal or dental—warrant awareness and responsible follow-up.
Dental health may not always be top of mind when starting a weight-loss journey, but it plays a vital role in overall wellness. As more is learned about these medications and their side effect profiles, patients are encouraged to remain informed, proactive, and supported by their care teams.
This article is intended for general information purposes only. It does not constitute medical or dental advice. Readers should consult qualified healthcare professionals for personalised guidance.